Australian And New Zealand Intensive Care Research Centre
Clinical trials sponsored by Australian And New Zealand Intensive Care Research Centre, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a Heart-Lung machine at the scene of a cardiac arrest double survival? Results expected Oct 2026 (estimated)
- ICU survivors at risk of brittle bones: new trial tests One-Time fix Results expected Feb 2027 (estimated)
- Can amino acids shield kidneys during life support? Results expected Aug 2027 (estimated)
-
ICU survivors at risk of brittle bones: new trial tests One-Time fix
Disease control Recruiting nowThis study tests whether a single dose of either zoledronic acid or denosumab can prevent bone loss in older adults who have been in the intensive care unit (ICU). The trial will include 450 women aged 50+ and men aged 70+ who spent at least 2 days in the ICU. Participants will r…
Phase 2 • Sponsor: Australian and New Zealand Intensive Care Research Centre • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
ECMO breakthrough? major trial aims to cut deadly complications
Knowledge-focused Recruiting nowThis study is testing different treatments to reduce major complications and improve survival in 600 adults who need ECMO—a machine that does the work of the heart and lungs. Researchers will compare how well these treatments work in the first 28 days. The goal is to find safer, …
Phase 3 • Sponsor: Australian and New Zealand Intensive Care Research Centre • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC